Niacin

Studied for: Hypercholesterolemia

Hypercholesterolemia

What the research found

Therapeutic doses of 1,500 to 3,000 mg/day significantly reduce LDL cholesterol, triglycerides, and apolipoprotein B while increasing HDL cholesterol. Niacin monotherapy (1–3 g/day) may be associated with reduced major coronary events.

Dose used in studies

1500 to 3000 mg/day

Side effects reported

Cutaneous flushing and pruritus, gastrointestinal complaints, hepatitis with sustained release formulas

References

Goldberg2000, Elam2000, D'Andrea2019, Saboori2023,

Not medical advice

Trials are run on specific people, for specific reasons, over a set period. Your medications, conditions and bloodwork can change what is safe for you. Ask a doctor or pharmacist before starting.